Cas:103058-87-3 5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE manufacturer & supplier

We serve Chemical Name:5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE CAS:103058-87-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE

Chemical Name:5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE
CAS.NO:103058-87-3
Synonyms:5-Bromo-2-methoxypyridine-3-carbaldehyde;(1-BOC-Piperidin-4-yl)acetic acid;MFCD05663521;5-Bromo-2-methoxypyridine-3-carboxaldehyde
Molecular Formula:C7H6BrNO2
Molecular Weight:216.03200
HS Code:2933399090

Physical and Chemical Properties:
Melting point:93-100ºC
Boiling point:278.5ºC at 760 mmHg
Density:1.606 g/cm3
Index of Refraction:1.591
PSA:39.19000
Exact Mass:214.95800
LogP:1.66520

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 5-Bromo-2-methoxypyridine-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-2-methoxypyridine-3-carboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD05663521 Use and application,(1-BOC-Piperidin-4-yl)acetic acid technical grade,usp/ep/jp grade.


Related News: But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US. 5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 5-BROMO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE factory But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.